The 2004-2005 pathology catalog from Zymed® Laboratories offers more than 600 products available for cancer diagnostics and research, including probes and kits for CISH™ (chromojenic in situ hybridization) detection of gene amplification and translocation, immunohistochemical detection kits, antibodies, and tissue microarrays. Routine and novel antibody tumor markers include MLH1/MSH2/MSH6, Thymidylate Synthase monoclonal cocktail, and EGFR antibodies for colorectal cancer, and Paxillin and JAB1 for breast cancer. The catalog also features VEGF for angiogenesis, LCA monoclonal cocktail/CD20 (L26)/polyclonal CD3 for lymphoma, STEAP for prostate cancer, c-Kit for GIST, Viroactiv® monoclonal HPV antibodies, phospho-EGFR, and MAP Kinase.
     Primary antibodies are available in 2ndGen Predilute format, economic concentrate format, and V-Line™ Predilute format for manual or automated IHC staining systems. Also featured is Zymed’s 96 slide high throughput MOZAIC™ automated immunostainer, SuperPicTure™ polymer IHC detection kits, and MaxArray™tissue microarray products.

Zymed Laboratories
(650) 871-4494; www.zymed.com